We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXTA icon
351
Axalta
AXTA
$7.98B
$36K 0.04%
1,605
-6,667
-81% -$136K
PD icon
352
PagerDuty
PD
$915M
$36K 0.04%
+1,253
New +$30.2K
RHP icon
353
Ryman Hospitality Properties
RHP
$7.7B
$36K 0.04%
+1,034
New +$34.3K
ROP icon
354
Roper Technologies
ROP
$39.5B
$36K 0.04%
+94
New +$33.7K
SBAC icon
355
SBA Communications
SBAC
$19.3B
$36K 0.04%
122
-148
-55% -$43.7K
THC icon
356
Tenet Healthcare
THC
$20.9B
$36K 0.04%
+1,980
New +$39K
MRO
357
DELISTED
Marathon Oil Corporation
MRO
$36K 0.04%
+5,842
New +$32.3K
ACHC icon
358
Acadia Healthcare
ACHC
$2.9B
$35K 0.04%
+1,412
New +$35.2K
LAMR icon
359
Lamar Advertising Co
LAMR
$15.6B
$35K 0.04%
522
-974
-65% -$59.5K
ELS icon
360
Equity Lifestyle Properties
ELS
$12.4B
$34K 0.04%
541
+88
+19% +$5.4K
NEO icon
361
NeoGenomics
NEO
$2.12B
$34K 0.04%
+1,093
New +$30.3K
EEFT icon
362
Euronet Worldwide
EEFT
$2.64B
$32K 0.04%
+332
New +$30.7K
FAST icon
363
Fastenal
FAST
$60.1B
$32K 0.04%
1,504
-7,938
-84% -$152K
SSB icon
364
SouthState Bank Corp
SSB
$10.7B
$32K 0.04%
+673
New +$35.1K
SRCL
365
DELISTED
Stericycle Inc
SRCL
$32K 0.04%
+580
New +$30.2K
CUZ icon
366
Cousins Properties
CUZ
$4.83B
$30K 0.03%
1,003
+501
+100% +$15K
MMM icon
367
3M
MMM
$94.4B
$30K 0.03%
227
-2,379
-91% -$300K
MDC
368
DELISTED
M.D.C. Holdings, Inc.
MDC
$30K 0.03%
+913
New +$25.2K
MSI icon
369
Motorola Solutions
MSI
$77.3B
$29K 0.03%
206
-375
-65% -$53.1K
TWOU
370
DELISTED
2U Inc
TWOU
$29K 0.03%
+25
New +$22.3K
BPOP icon
371
Popular Inc
BPOP
$11.2B
$28K 0.03%
+742
New +$27.6K
PPL
372
PPL Corp
PPL
$26.5B
$28K 0.03%
+1,099
New +$28.6K
MIDD icon
373
Middleby
MIDD
$5.43B
$27K 0.03%
343
-831
-71% -$53.8K
XRAY icon
374
Dentsply Sirona
XRAY
$2.31B
$27K 0.03%
+616
New +$26K
CTRA
375
DELISTED
Coterra Energy
CTRA
$26K 0.03%
+1,534
New +$29.7K

Similar funds

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.